Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -673 | -472 | -24,401 | -13,542 | -39,594 |
| Depreciation Amortization | N/A | N/A | 369 | 188 | 931 |
| Accounts receivable | N/A | N/A | -334 | -18 | 342 |
| Accounts payable and accrued liabilities | N/A | N/A | -458 | 141 | 795 |
| Other Working Capital | 291 | 267 | -2,064 | -775 | 4,420 |
| Other Operating Activity | 9 | 0 | 2,387 | 746 | 1,191 |
| Operating Cash Flow | $-372 | $-205 | $-24,501 | $-13,260 | $-31,915 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -472 | -359 | -254 |
| Other Investing Activity | 0 | 0 | 117 | 117 | -230 |
| Investing Cash Flow | $N/A | $N/A | $-355 | $-242 | $-484 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 198 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 21,000 |
| Debt Repayment | N/A | N/A | -3,900 | -1,932 | -3,321 |
| Common Stock Issued | N/A | N/A | 41 | 41 | 39,813 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -359 |
| Financing Cash Flow | $198 | $N/A | $-3,859 | $-1,891 | $57,133 |
| Beginning Cash Position | 219 | 219 | 75,908 | 75,908 | 51,174 |
| End Cash Position | 45 | 14 | 47,193 | 60,515 | 75,908 |
| Net Cash Flow | $-175 | $-205 | $-28,715 | $-15,393 | $24,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -372 | -205 | -24,501 | -13,260 | -31,915 |
| Capital Expenditure | N/A | N/A | -472 | -359 | -277 |
| Free Cash Flow | -372 | -205 | -24,973 | -13,619 | -32,192 |